Aa. Quyyumi et al., CORONARY VASCULAR NITRIC-OXIDE ACTIVITY IN HYPERTENSION AND HYPERCHOLESTEROLEMIA - COMPARISON OF ACETYLCHOLINE AND SUBSTANCE-P, Circulation, 95(1), 1997, pp. 104-110
Background Whether the abnormal responses of the human coronary circul
ation to acetylcholine in patients with hypertension and hypercholeste
rolemia extend to other, nonmuscarinic stimulators of the endothelium
and whether this signifies a specific abnormality of NO is not known.
Methods and Results We studied 26 patients with angiographically norma
l coronary arteries, 10 without risk factors, and 16 with either hyper
tension (n=9) and/or hypercholesterolemia (n=10). Dose-response curves
were performed with acetylcholine, substance P, and sodium nitropruss
ide before and after N-G-monomethyl-L-arginine (L-NMMA). Substance P p
roduced predominantly epicardial coronary dilation, whereas the dilati
ng effect of acetylcholine was mainly microvascular. There was no corr
elation between the responses to the two drugs. L-NMMA did not affect
the response to sodium nitroprusside, but it suppressed dilation in re
sponse to both substance P and acetylcholine, suggesting that the latt
er promote bioavailability of NO from the coronary vascular endotheliu
m. Compared with patients without risks, those with hypercholesterolem
ia and hypertension had significantly reduced vasodilation with substa
nce P:21% versus 12.6% (P=.004) increase in epicardial coronary diamet
er and 35% versus 19% (P<.05) decrease in vascular resistance. Similar
differences were noted with acetylcholine but not with sodium nitropr
usside or adenosine. Epicardial and microvascular dilations with subst
ance P or acetylcholine after L-NMMA were similar in patients with and
without risk factors, indicating that the reduced effect of endotheli
um-dependent vasodilators in those with hypertension and hypercholeste
rolemia is due to diminished NO activity. Conclusions (1) Substance P-
and acetylcholine-induced coronary vasodilation, like that to acetylc
holine, is at least partly due to stimulation of NO activity, indicati
ng that the dysfunction of the coronary vascular endothelial cell laye
r is not restricted to muscarinic receptors. (2) Hypertension and hype
rcholesterolemia are associated with depression of both basal and phar
macologically stimulated bioavailability of NO.